IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 176 filers reported holding IVERIC BIO INC in Q4 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $316,687,000 | +89.3% | 8,050,000 | +4.9% | 4.30% | +73.2% |
Q1 2023 | $167,281,500 | +15.8% | 7,675,000 | +13.7% | 2.48% | +14.8% |
Q4 2022 | $144,517,500 | +36.5% | 6,750,000 | +14.4% | 2.16% | +10.5% |
Q3 2022 | $105,846,000 | +54.5% | 5,900,000 | -17.1% | 1.96% | +44.5% |
Q2 2022 | $68,494,000 | -43.9% | 7,120,000 | -1.8% | 1.35% | -39.3% |
Q1 2022 | $122,018,000 | +0.7% | 7,250,000 | 0.0% | 2.23% | +8.0% |
Q4 2021 | $121,220,000 | +5.1% | 7,250,000 | +2.1% | 2.06% | +13.9% |
Q3 2021 | $115,304,000 | +184.4% | 7,100,000 | +10.5% | 1.81% | +156.9% |
Q2 2021 | $40,542,000 | -9.5% | 6,425,000 | -11.4% | 0.70% | -8.9% |
Q1 2021 | $44,805,000 | -10.6% | 7,250,000 | 0.0% | 0.77% | -10.3% |
Q4 2020 | $50,098,000 | +22.5% | 7,250,000 | 0.0% | 0.86% | +48.5% |
Q3 2020 | $40,890,000 | +12.9% | 7,250,000 | +2.1% | 0.58% | -18.9% |
Q2 2020 | $36,210,000 | – | 7,100,000 | – | 0.72% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 1,729,041 | $10,685,000 | 4.26% |
Soleus Capital Management, L.P. | 3,380,979 | $20,894,000 | 3.76% |
ACUTA CAPITAL PARTNERS, LLC | 1,579,093 | $9,759,000 | 3.52% |
Stonepine Capital Management, LLC | 875,180 | $5,409,000 | 2.92% |
Samsara BioCapital, LLC | 2,372,476 | $14,664,000 | 2.70% |
Ghost Tree Capital, LLC | 1,125,000 | $6,953,000 | 1.63% |
Octagon Capital Advisors LP | 680,036 | $4,203,000 | 1.58% |
Altium Capital Management LP | 902,633 | $5,578,000 | 1.55% |
Vivo Capital, LLC | 5,966,527 | $36,873,000 | 1.30% |
FRAZIER MANAGEMENT LLC | 2,544,500 | $15,725,000 | 1.26% |